06/07/2026 – Second-Generation of Deuterium-Substituted Glutamate Uptake Enhancers Exhibit Superior Drug-Like Properties in Preclinical Evaluation. This is a key element of the product development work at iQure Pharma.
This important publication will be of greatest interest to our investors focused on pharmaceutical technical development.